Papers
4
Total Citations
31
H-Index
4
About
Dr. Jong Ha Hwang is a leading figure in gynecologic oncology, with a research focus on advancing minimally invasive surgical techniques for the treatment of gynecologic cancers. His major contributions center on rigorous comparative effectiveness research, particularly through meta-analyses that evaluate the safety and efficacy of robotic versus laparoscopic approaches. Notably, his 2019 meta-analysis of 23 studies (10 citations) demonstrated that robotic radical hysterectomy is not superior to laparoscopy in terms of perioperative urologic complications, providing critical guidance for surgical decision-making. He further explored lymphatic complications in a 2023 meta-analysis (7 citations), clarifying risks associated with these procedures. Dr. Hwang is also at the forefront of innovation, leading the KGOG 4002/GYANT study (2024, 8 citations), a prospective multicenter trial that established the feasibility and safety of the ArtiSential articulating laparoscopic system for early-stage gynecologic cancer. His work extends to benign conditions, as shown in a 2024 study (6 citations) evaluating ArtiSential for myomectomy. Through these impactful studies, Dr. Hwang is shaping the future of gynecologic surgery by systematically comparing existing technologies and validating novel instruments to improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4